Surgery
Volume 148, Issue 1 , Pages 110-118 , July 2010

Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model

  • Robert S. Crawford, MD

      Affiliations

    • Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • Hassan Albadawi, MD

      Affiliations

    • Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • Marvin D. Atkins, MD

      Affiliations

    • Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • John E. Jones, MD

      Affiliations

    • Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • Hyung-Jin Yoo, MA

      Affiliations

    • Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA
    • ,
  • Mark F. Conrad, MD

      Affiliations

    • Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • W. Gerald Austen Jr., MD

      Affiliations

    • Division of Plastic and Reconstructive Surgery of the General Surgical Services, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • Michael T. Watkins, MD

      Affiliations

    • Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • Corresponding Author InformationReprint requests: Michael T. Watkins, MD, Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, 15 Parkman Street, WAC 440, Boston, MA 02114.

,Accepted 7 December 2009.

References 

  1. Wagner HJ, Starck EE, Reuter P. Long-term results of percutaneous aspiration embolectomy. Cardiovasc Intervent Radiol. 1994;17:241–246
  2. Braithwaite BD, Davies B, Birch PA, Heather BP, Earnshaw JJ. Management of acute leg ischaemia in the elderly. Br J Surg. 1998;85:217–220
  3. Jivegard L, Holm J, Schersten T. Acute limb ischemia due to arterial embolism or thrombosis: influence of limb ischemia versus pre-existing cardiac disease on postoperative mortality rate. J Cardiovasc Surg. 1988;29:32–36
  4. Kyriakides C, Austen WG, Wang Y, Favuzza J, Moore FD, Hechtman HB. Neutrophil mediated remote organ injury after lower torso ischemia and reperfusion is selectin and complement dependent. J Trauma. 2000;48:32–38
  5. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol. 1987;253:H699–H703
  6. Liu K, Chen LE, Seaber AV, Urbaniak JR. S-nitroso-N-acetylcysteine protects skeletal muscle against reperfusion injury. Microsurgery. 1998;18:299–305
  7. Hobson RW, Neville R, Watanabe B, Canady J, Wright JG, Belkin M. Role of heparin in reducing skeletal muscle infarction in ischemia-reperfusion. Microcirc Endothelium Lymphatics. 1989;5:259–276
  8. Woo YJ, Taylor MD, Cohen JE, Jayasankar V, Bish LT, Burdick J, et al. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. J Thorac Cardiovasc Surg. 2004;127:1262–1269
  9. Conrad MF, Albadawi H, Stone DH, Crawford RS, Entabi F, Watkins MT. Local administration of the poly ADP-ribose polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury. J Surg Res. 2006;135:233–237
  10. Hua HT, Albadawi H, Entabi F, Conrad M, Stoner MC, Meriam BT, et al. Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion. Arch Surg. 2005;140:344–352
  11. Black JH, Casey PJ, Albadawi H, Cambria RP, Watkins MT. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion. J Am Coll Surg. 2006;203:44–53
  12. Patel P, Qi WN, Allen DM, Chen LE, Seaber AV, Stamler JS, et al. Inhibition of iNOS with 1400W improves contractile function and alters nos gene and protein expression in reperfused skeletal muscle. Microsurgery. 2004;24:324–331
  13. Cunha MS, da Silva JC, Nakamoto HA, Ferreira MC. Study of warm ischemia followed by reperfusion on a lower limb model in rats: effect of allopurinol and streptokinase. Clinics. 2005;60:213–220
  14. Wilhelm MP, Schlensak C, Hoh A, Knipping L, Mangold G, Rojas DD, et al. Controlled reperfusion using a simplified perfusion system preserves function after acute and persistent limb ischemia: a preliminary study. J Vasc Surg. 2005;42:690–694
  15. Ouriel K, Veith F, Sasahara A. A comparions of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med. 1998;339:1105–1111
  16. Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev. 2002;54:375–429
  17. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, et al. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 1999;18:4446–4454
  18. Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabo C, et al. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med. 2001;7:255–260
  19. Jagtap P, Soriano FG, Virag L, Liaudet L, Mabley J, Szabo E, et al. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med. 2002;30:1071–1082
  20. McCormack MC, Kwon E, Eberlin KR, Randolph M, Friend DS, Thomas AC, et al. Development of reproducible histologic injury severity scores: skeletal muscle reperfusion injury. Surgery. 2008;143:126–133
  21. Crawford RS, Hashmi F, Jones JE, Albadawi H, McCormack M, Eberlin K, et al. A novel model of acute murine hind limb ischemia. Am J Physiol Heart Circ Physiol. 2007;292:830–837
  22. Bonheur JA, Albadawi H, Patton GM, Watkins MT. A noninvasive murine model of hind limb ischemia-reperfusion injury. J Surg Res. 2004;116:55–63
  23. Goldfarb RD, Marton A, Szabo E, Virag L, Salzman AL, Glock D, et al. Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med. 2002;30:974–980
  24. Szabo G, Bahrle S, Stumpf N, Sonnenberg K, Szabo EE, Pacher P, et al. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res. 2002;90:100–106
  25. Yassin MM, Barros D'Sa AA, Parks G, Abdulkadir AS, Halliday I, Rowlands BJ. Mortality following lower limb ischemia-reperfusion: a systemic inflammatory response?. World J Surg. 1996;20:961–967
  26. Yassin MM, Harkin DW, Barros D'Sa AA, Halliday MI, Rowlands BJ. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002;26:115–121
  27. Abbruzzese TA, Albadawi H, Kang J, Patel VI, Yoo JH, Lamuraglia GM, et al. Enoxaparin does not ameliorate limb ischemia-reperfusion injury. J Surg Res. 2008;147:260–266
  28. Hua HT, Al-Badawi H, Entabi F, Stoner MC, Diamond RE, Bonheur JA, et al. CXC chemokine expression and synthesis in skeletal muscle during ischemia/reperfusion. J Vasc Surg. 2005;42:337–343
  29. Wakai M, Winter D, Street J, O'Sullivan R, Wang J, Redmond H. Inosine attenuates tourniquet induced skeletal muscle reperfusion injury. J Surg Res. 2001;99:311–315
  30. Szabo C, Biser A, Benko R, Bottinger E, Susztak K. Poly (ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes. 2006;55:3004–3012
  31. Mabley JG, Jagtap P, Perretti M, Getting SJ, Salzman AL, Virag L, et al. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res. 2001;50:561–569
  32. Rubin BB, Liauw S, Tittley J, Romaschin AD, Walker PM. Prolonged adenine nucleotide resynthesis and reperfusion injury in postischemic skeletal muscle. Am J Physiol. 1992;262:H1538–H1547
  33. Ariumi Y, Masutani M, Copeland TD, Mimori T, Sugimura T, Shimotohno K, et al. Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro. Oncogene. 1999;18:4616–4625
  34. Ethier C, Labelle Y, Poirier GG. PARP-1-induced cell death through inhibition of the MEK/ERK pathway in MNNG-treated HeLa cells. Apoptosis. 2007;12:2037–2049
  35. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest. 2003;112:1049–1057
  36. Gute DC, Ishida T, Yarimizu K, Korthuis RJ. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem. 1998;179:169–187
  37. Boyle EM, Kovacich JC, Hebert CA, Canty TG, Chi E, Morgan EN, et al. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 1998;116:114–121
  38. Soriano FG, Pacher P, Mabley J, Liaudet L, Szabo C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res. 2001;89:684–691
  39. Tuma RS. PARP inhibitors: will the new class of drugs match the hype?. J Natl Cancer Inst. 2009;101:1230–1232

 Supported by the Pacific Vascular Research Foundation, the American Diabetes Association, the Geneen Fund at the Massachusetts General Hospital, and Grant 1R01AR055843 from the National Institutes of Health.

PII: S0039-6060(09)00798-3

doi: 10.1016/j.surg.2009.12.006

Surgery
Volume 148, Issue 1 , Pages 110-118 , July 2010

Article Tools

* Image Usage & Resolution